. The antibody aducanumab reduces Aβ plaques in Alzheimer's disease. Nature. 2016 Aug 31;537(7618):50-6. PubMed.

Recommends

Please login to recommend the paper.

This paper appears in the following:

News

  1. Paper Alert: Aducanumab Phase 1b Study Published

Therapeutics

  1. Aducanumab